Two growth-hormone secretagogues often studied together — a GHRH analog vs a GHRP. Here's a neutral, sourced side-by-side — no hype, every claim links to its evidence.
Also: CJC-1295 with DAC, Modified GRF 1-29 (no DAC)
CJC-1295 is a chemical made in labs that acts like a tiny messenger in the body. It belongs to a group called peptides, which are small chains of building blocks.
Also: GHRP
Ipamorelin is a lab-made substance known as a growth hormone releasing peptide. It belongs to a group of compounds that tell the body to make more natural growth hormone.
| CJC-1295 | Ipamorelin | |
|---|---|---|
| Research status | Preclinical | Preclinical |
| Benefits documented | 176 | 100 |
| Research citations | 98 | 90 |
| Dosing routes | Subcutaneous | Subcutaneous |
| Known side effects | 76 | 23 |
Top documented benefits — backed by research.
Reported protocols — research only, not medical advice.
Key studies — click through to verify each on PubMed.
98 sourced studies
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.
Once-daily administration of CJC-1295
Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse
Neither is a “winner” — they suit different goals. Compare the documented benefits and evidence above against what you’re actually trying to achieve, note the research status (approved vs research-stage), and read each full guide before deciding. Many people also stack peptides rather than pick one.
Source CJC-1295
Source Ipamorelin